Phillips MJ et al
My takeaway The oral obesity race is rapidly evolving from who loses the most weight to who patients can stay on the longest. As multiple oral GLP-1 therapies converge around similar efficacy, long-term tolerability, convenience, and real-world persistence are becoming the key commercial battleground
While its formulation appeals to plant-based diet enthusiasts and those seeking convenience, the proprietary blend and lack of long-term research invite caution
Short-term storage at 2-8C is acceptable
26 Subjects were administered 0.75 mg of liraglutide as a single dose, and evaluated after a 72-hour period to determine if hepatic impairment influenced liraglutides pharmacokinetic and safety profile
Zhao M, Zhao L, Xiong X, He Y, Huang W, Liu Z, et al